Migraine

Disorder

About

Thing
Cofactor will automatically discover the description of this topic and display it here.

Pronunciation

English

Migraine

Migraine
SpellingMigraine
Pronunciation[Migraine]

Mentions

Migraine sufferers now have a new tool in their arsenal to fight the debilitating headaches with federal approval of Allergan’s first oral medication proven to ease migraine symptoms within two hours — even after they’ve started.

The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Ubrelvy is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.

The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.

The U.S. Food and Drug Administration has approved a new drug to treat migraines.

What was once a debilitating condition may now be easily and quickly treatable thanks to a recent FDA announcement on the approval of a new migraine treatment. The medication, Ubrelvy, was found to work in as little as two hours to offer relief to migraine patients.

New to Cofactor?

Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.

See also: